CSPC Pharmaceutical Group (FRA:CVG) Other Net Income (Loss) : €-0 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group Other Net Income (Loss)?

CSPC Pharmaceutical Group's Other Net Income (Loss) for the three months ended in Dec. 2023 was €-0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0 Mil.

CSPC Pharmaceutical Group's quarterly Other Net Income (Loss) declined from Jun. 2023 (€0 Mil) to Sep. 2023 (€-0 Mil) and declined from Sep. 2023 (€-0 Mil) to Dec. 2023 (€-0 Mil).

CSPC Pharmaceutical Group's annual Other Net Income (Loss) increased from Dec. 2021 (€0 Mil) to Dec. 2022 (€0 Mil) but then declined from Dec. 2022 (€0 Mil) to Dec. 2023 (€-0 Mil).

CSPC Pharmaceutical Group Other Net Income (Loss) Historical Data

The historical data trend for CSPC Pharmaceutical Group's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Other Net Income (Loss) Chart

CSPC Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

CSPC Pharmaceutical Group Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

CSPC Pharmaceutical Group Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0 Mil.

CSPC Pharmaceutical Group Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group (FRA:CVG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (FRA:CVG) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

CSPCY:USA CHJTF:USA 01093:Hong Kong

Address

No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.